Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85 EUR | +0.35% | +7.05% | +41.20% |
04-02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
03-12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 85.07 | 103.39 | 110.38 |
Spread/Res. | -0.08% | -17.79% | -22.99% |
Spread/Supp. | +4.17% | +39.00% | +49.78% |
Support | 81.60 | 61.15 | 56.75 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.